For the quarter ending 2026-03-31, ALTO had -$4,030K decrease in cash & cash equivalents over the period. $3,300K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 4,271 | 21,806 | 14,208 | -22,676 |
| Depreciation and amortization | 6,366 | 6,328 | 6,257 | 12,631 |
| Asset impairments | - | 803 | - | - |
| Transferable tax credits, net, generated | 3,900 | 7,500 | - | - |
| Inventory valuation | - | -642 | - | 1,649 |
| Gains on derivative instruments | 8,416 | -2,111 | 5,808 | 4,371 |
| Non-cash compensation | 705 | 842 | 706 | 1,474 |
| Amortization of deferred financing fees | 249 | 254 | 257 | 502 |
| Amortization of debt discount | 198 | 202 | 202 | 397 |
| Credit loss (recovery) | -15 | 57 | -3 | -1 |
| Accounts receivable | 4,616 | -134 | -2,700 | -480 |
| Inventories | -8,845 | 9,293 | -2,126 | 5,448 |
| Other assets | -1,918 | 444 | -481 | -2,242 |
| Operating leases | -1,675 | -1,706 | -1,703 | -3,180 |
| Accounts payable and accrued liabilities | 279 | -5,061 | 5,010 | -2,778 |
| Net cash provided by (used in) operating activities | 4,209 | 9,540 | 22,784 | -19,079 |
| Additions to property and equipment | 909 | 1,948 | 1,633 | 1,016 |
| Deferred purchase price payments for eagle alcohol | - | 0 | 0 | 2,240 |
| Purchase of kodiak carbonic, net of cash acquired | - | 0 | 0 | 7,278 |
| Excess insurance proceeds | - | 6,688 | - | - |
| Net cash used in investing activities | -909 | 4,740 | -1,633 | -10,534 |
| Net (payments on) proceeds from kinergys line of credit | - | -16,427 | 6,336 | - |
| Net proceeds from kinergys line of credit | -14,938 | - | - | 24,520 |
| Principal payments on term debt | 16,600 | 5,000 | - | - |
| Preferred stock dividends paid | 312 | 319 | 319 | 627 |
| Net cash (used in) provided by financing activities | -7,330 | -21,746 | -18,503 | 23,893 |
| Net decrease in cash, cash equivalents and restricted cash | -4,030 | -7,466 | 2,648 | -5,720 |
| Cash, cash equivalents and restricted cash at beginning of period | 25,673 | 33,139 | 36,211 | - |
| Cash, cash equivalents and restricted cash at end of period | 21,643 | 25,673 | 33,139 | - |
Alto Ingredients, Inc. (ALTO)
Alto Ingredients, Inc. (ALTO)